In this episode of the “Cancer Horizons” podcast, a physician assistant recalls his experience as a frontline health care worker during the COVID-19 pandemic and what it was like to get diagnosed with multiple myeloma during such a chaotic time.
Ryan Johnson is a physician assistant in the emergency department who was working through the peak of the COVID-19 pandemic when he learned he had multiple myeloma. At the time, he questioned how he would remain safe and healthy, and if he’d be able to produce antibodies after receiving the vaccine.
Johnson answers these questions and more in this episode of the “Cancer Horizons” podcast, as he paints a vivid picture of what it was like to care for patients with COVID-19 while undergoing treatment for his cancer.
“I would like to get back to the old way of life and being able to go without a mask and being able to go to people's houses, you know, and just not have to worry about that stuff,” Johnson said in an interview with CURE®. “But it's the reality that the world isn't like that for me at this time.”
For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Benefits Outweigh Risks as FDA Inspects CAR-T Cell Therapy-Related Cancer
November 29th 2023The FDA announced rare instances of secondary diseases or cancers from CAR-T cell therapy, though this is not the first time that oncology treatments have been associated with secondary diseases.
Read More
Fertility Research ‘Long Overdue’ for Patients With Cervical Cancer
November 30th 2023Cervical cancer survivor Kate Weissman talks recent research on follow-up visits for patients after fertility-sparing surgery, and explains why it’s ‘something that the cervical cancer community is owed.’
Listen
Patrick Dempsey Reflects on His Nonprofit, ‘General Hospital’ Star Talks Cancer and More
November 10th 2023From actor Patrick Dempsey saying that his late mother would be proud of his work at The Dempsey Center to a “General Hospital” actor discussing his cancer treatments, here’s what’s happening in the oncology space this week.
Read More